Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be ...

Jimmy McMillan, 69, of West Columbia felt his health growing worse as his heart failure progressed. “I would have trouble just walking down to the mailbox and back without having to stop and catch my ...

Children born with defects that impair the heart's lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic tube called a shunt to ...

PHOENIX -- The functional and quality-of-life benefits of creating a left-to-right shunt in the interatrial septum to offload failing hearts held up over the midterm in a series of small feasibility ...

Patients with heart failure who had a small shunt inserted between the heart's left and right atria did not see any significant benefits overall compared with those who received a placebo procedure ...

Congenital heart defects (CHDs) are among the top eight causes of infant mortality worldwide. Annually, CHDs affect around 40,000 infants in the United States, with approximately one in four having a ...

For well-treated patients refractory to standard medications, the Ventura interatrial shunt was no better than sham in terms of primary effectiveness over nearly 2 years, defined by a hierarchical ...

SHREVEPORT, La. -- LSU Health Shreveport is one of only 25 sites around the country participating in a major clinical trial for individuals with stiff heart syndrome. About half of of patients with ...

DENVER, Aug. 19, 2024 — Children born with defects that impair the heart’s lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic ...

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

An ongoing trial at the Medical University of South Carolina is looking for a breakthrough for patients dealing with heart failure.